Stoler M H
Department of Pathology, University of Virginia Health System, Charlottesville, USA.
Mod Pathol. 2000 Mar;13(3):275-84. doi: 10.1038/modpathol.3880048.
The Pap smear unquestionably is a successful screening test for cervical cancer. However, recent advances in technology have raised questions regarding whether the conventional Pap smear is still the standard of care. This article relates issues of screening and cost-effectiveness to the state of the art in thin layer preparations, cytology automation, human papillomavirus screening, human papillomavirus vaccines, and other cervical screening adjuncts. Perhaps nowhere in medicine is clinical decision making being more strongly influenced by market and other external forces than in cervical cytopathology.
巴氏涂片无疑是一种成功的宫颈癌筛查检测方法。然而，技术的最新进展引发了关于传统巴氏涂片是否仍是标准医疗手段的疑问。本文将筛查问题和成本效益与薄层制片、细胞学自动化、人乳头瘤病毒筛查、人乳头瘤病毒疫苗及其他宫颈癌筛查辅助手段的技术现状联系起来。在医学领域，或许没有哪个领域的临床决策比宫颈细胞病理学更受市场和其他外部力量的强烈影响。
